ArticleCell communication and signaling : CCS2025

The Src family kinase inhibitor drug Dasatinib and glucocorticoids display synergistic activity against tongue squamous cell carcinoma and reduce MET kinase activity.

Ali N A Hmedat et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.